- Home
- JXG vs CELZ Comparison
JXG vs CELZ Comparison
Compare JXG & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JXG | CELZ |
|---|---|---|
| Founded | N/A | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 7.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JXG | CELZ |
|---|---|---|
| Price | $4.07 | $1.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.2K | ★ 55.3K |
| Earning Date | 11-05-2025 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.26 | N/A |
| Revenue | ★ $46,835,624.00 | $6,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.77 | ★ N/A |
| Revenue Growth | ★ 21.68 | N/A |
| 52 Week Low | $3.01 | $1.50 |
| 52 Week High | $45.15 | $6.90 |
Technical Indicators
Market Signals| Indicator | JXG | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 38.64 | 41.14 |
| Support Level | $3.91 | $1.78 |
| Resistance Level | $4.24 | $1.98 |
| Average True Range (ATR) | 0.33 | 0.13 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 33.56 | 15.91 |
Price Performance
Historical ComparisonAbout JXG JX Luxventure Limited
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.